POL · Class II · 21 CFR 882.5600

FDA Product Code POL: Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment

Mechanical thrombectomy for acute ischemic stroke has transformed neurological outcomes. FDA product code POL covers neurovascular mechanical thrombectomy devices for acute ischemic stroke treatment.

These stent retrievers and aspiration systems are deployed into occluded intracranial arteries to capture and remove the obstructing clot, restoring cerebral blood flow within the critical treatment window. They have become the standard of care for large vessel occlusion stroke.

POL devices are Class II medical devices, regulated under 21 CFR 882.5600 and reviewed by the FDA Neurology panel.

Leading manufacturers include Micro Therapeutics, Inc. d/b/a ev3 Neurovascular, Stryker and Stryker Neurovascular.

18
Total
17
Cleared
144d
Avg days
2016
Since
Declining activity - 1 submissions in the last 2 years vs 3 in the prior period
Review times increasing: avg 175d recently vs 142d historically

FDA 510(k) Cleared Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment Devices (Product Code POL)

18 devices
1–18 of 18
Cleared Feb 28, 2025
pRESET Delta Thrombectomy Device and pRESET Delta LITE Thrombectomy Device
K242676
Phenox Limited
Neurology · 175d
Cleared Oct 21, 2023
pRESET LITE Thrombectomy Device
K231539
Phenox Limited
Neurology · 144d
Cleared Mar 29, 2023
Trevo NXT ProVue Retriever
K223305
Stryker Neurovascular
Neurology · 153d
Cleared Jan 20, 2023
pRESET Thrombectomy Device
K222848
Phenox Limited
Neurology · 121d
Cleared Aug 27, 2021
Trevo NXT ProVue Retriever
K210502
Stryker Neurovascular
Neurology · 186d
Cleared Mar 01, 2021
Solitaire X Revascularization Device
K203358
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
Neurology · 105d
Cleared Dec 29, 2020
Trevo XP ProVue Retriever and Trevo NXT™ ProVue Retriever
K203219
Stryker Neurovascular
Neurology · 57d
Cleared Nov 20, 2020
Solitaire Platinum Revascularization Device, Solitaire X Revascularization Device (Solitaire Revascularization Device)
K193576
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
Neurology · 333d
Cleared Feb 07, 2020
Trevo NXT ProVue Retriever
K200117
Stryker
Neurology · 17d
Cleared Nov 22, 2019
Trevo NXT ProVue Retriever
K192207
Stryker
Neurology · 100d
Cleared Jun 25, 2019
Trevo XP ProVue Retriever
K190779
Stryker
Neurology · 90d
Cleared Mar 06, 2019
Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device)
K181807
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
Neurology · 243d
Cleared Jan 29, 2019
Solitaire 4 Revascularization Device
K183022
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
Neurology · 89d
Cleared Oct 25, 2018
Solitare Platinum Revascularization Device
K181186
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular
Neurology · 175d
Cleared Aug 24, 2018
Solitaire 2 and Solitaire Platinum Revascularization Device
K181060
Medtronic Neurovascular
Neurology · 123d
Cleared Feb 15, 2018
Trevo Pro Vue Retriever and Trevo XP Pro Vue Retriever (Trevo Retriever)
K173352
Concentric Medical, Inc.
Neurology · 113d

About Product Code POL - Regulatory Context

510(k) Submission Activity

18 total 510(k) submissions under product code POL since 2016, with 17 receiving FDA clearance (average review time: 144 days).

Submission volume has declined in recent years - 1 submissions in the last 24 months compared to 3 in the prior period.

FDA 510(k) Review Time - POL Product Code

Recent submissions under POL have taken an average of 175 days to reach a decision - up from 142 days historically. Manufacturers should account for longer review timelines in current project planning.

POL devices are reviewed by the Neurology panel. Browse all Neurology devices →